癌症患者非计划ICU入院的临床特征、器官支持使用与结局趋势:一项多中心队列研究
该多中心队列研究回顾性分析了2011年7月至2019年6月92个内科-外科ICU收治的32,096例非计划入院的癌症患者(占所有ICU收治的8.7%,实体瘤90%,血液恶性肿瘤10%),采用贝叶斯分层模型评估调整后死亡率趋势,并用竞争风险模型评估ICU住院时间变化。结果显示癌症患者占用床/日增加超过30%,总体调整死亡率下降9.2%(95%可信区间13.1-5.6%);无需器官支持者死亡率下降9.6%,仅需机械通气者下降11%,而同时需要机械通气、血管升压药和透析者仅下降3.9%。作者认为过去8年危重癌症患者结局改善,但肺癌、需多器官支持及体能状态差者结局仍差。
要点
- 总体调整死亡率下降9.2%(95%可信区间13.1-5.6%),无需器官支持者下降9.6%,仅需机械通气者下降11%。
- 同时需要机械通气、血管升压药和透析者死亡率仅下降3.9%,多器官支持患者结局改善有限。
- 肺癌患者死亡率下降幅度最小,体能状态越差生存获益越少。
- 癌症患者占用ICU床/日增加超过30%,占所有ICU收治的8.7%。
适用人群与场景
- 2011年7月至2019年6月期间92个内科-外科ICU收治的所有非计划入院的癌症患者。
- 实体瘤占90%,血液恶性肿瘤占10%;占所有ICU收治的8.7%。
研究设计与关键结果
- 研究类型为多中心队列研究,回顾性分析前瞻性收集的数据,纳入92个内科-外科ICU的32,096例非计划入院的癌症患者。
- 癌症患者占用床/日增加超过30%;总体调整死亡率下降9.2%(95%可信区间13.1-5.6%)。
- 无需器官支持者死亡率下降9.6%,仅需机械通气者下降11%,同时需要机械通气、血管升压药和透析者死亡率下降3.9%。
- 肺癌患者死亡率下降幅度最小;体能状态越差,生存获益越少。
证据类型、等级与局限
- 证据类型:多中心队列研究(回顾性分析前瞻性收集的数据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为过去8年危重癌症患者结局改善,死亡率和ICU住院时间均下降,提示整体诊疗水平提升。
- 作者指出肺癌、需要多器官支持及体能状态差的癌症患者结局仍差。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
- 另有 3 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开
PURPOSE: To describe trends in outcomes of cancer patients with unplanned admissions to intensive-care units (ICU) according to cancer type, organ support use, and performance status (PS) over an 8-year period.
METHODS: We retrospectively analyzed prospectively collected data from all cancer patients admitted to 92 medical-surgical ICUs from July/2011 to June/2019. We assessed trends in mortality through a Bayesian hierarchical model adjusted for relevant clinical confounders and whether there was a reduction in ICU length-of-stay (LOS) over time using a competing risk model.
RESULTS: 32,096 patients (8.7% of all ICU admissions; solid tumors, 90%; hematological malignancies, 10%) were studied. Bed/days use by cancer patients increased up to more than 30% during the period. Overall adjusted mortality decreased by 9.2% [95% credible interval (CI), 13.1-5.6%]. The largest reductions in mortality occurred in patients without need for organ support (9.6%) and in those with need for mechanical ventilation (MV) only (11%). Smallest reductions occurred in patients requiring MV, vasopressors, and dialysis (3.9%) simultaneously. Survival gains over time decreased as PS worsened. Lung cancer patients had the lowest decrease in mortality. Each year was associated with a lower sub-hazard for ICU death [SHR 0.93 (0.91-0.94)] and a higher chance of being discharged alive from the ICU earlier [SHR 1.01 (1-1.01)].
CONCLUSION: Outcomes in critically ill cancer patients improved in the past 8 years, with reductions in both mortality and ICU LOS, suggesting improvements in overall care. However, outcomes remained poor in patients with lung cancer, requiring multiple organ support and compromised PS.
参考来源
- Zampieri FG, Romano TG, Salluh JIF, et al. Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study. Intensive Care Med. 2020. PMID: 32770267. doi:10.1007/s00134-020-06184-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。